Abstract
We sought markers of survival and disease control among patients treated for limited-stage small-cell lung cancer. High pretreatment total lymphocyte count was linked with superior (and high neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with inferior) median and 2-year overall survival, findings confirmed in multivariate Cox regression. Baseline lymphopenia was an indicator of poor prognosis in patients with limited-stage small-cell lung cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 117-123 |
Number of pages | 7 |
Journal | Clinical Lung Cancer |
Volume | 20 |
Issue number | 2 |
DOIs | |
State | Published - Mar 2019 |
Keywords
- Chemoradiation
- Lymphopenia
- Neutrophil-to-lymphocyte ratio
- Overall survival
- Small cell lung cancer
ASJC Scopus subject areas
- Oncology
- Pulmonary and Respiratory Medicine
- Cancer Research